Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2022-01-06 00:00:00 ET · period of report 2022-01-04 · accession 0001567619-22-000729 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-06 | 2022-01-04 | MEDP | Medpace Investors, LLC | 10% | S - Sale | $213.44 | -3,338 | 5.48M | -0.1% | -$712.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-04 | S | D | 3,338 | $213.44 | 5,483,019 | D | — | — | (F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $216.175. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |